Long Noncoding RNA HOXC-AS2 Inhibits Cell Proliferation in Colorectal Cancer by Regulating UBE2L6 Expression Through Sponging miR-146b-5p

Author:

Chen Shihao1,Wang Xin2,Niu Mengye1,Shang Fangjian1,Liu Ying1,Guo Shang1,Zheng Qian1,Li Dongyun1,Su Xingkai1,Zhao Zengren1,Jiang Xia1

Affiliation:

1. Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, People’s Republic of China

2. Department of Pathology, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, People’s Republic of China

Abstract

It has been demonstrated that lncRNA HOXC-AS2 regulates the tumorigenesis and progression of multiple tumors. In present study we explored the biological function of HOXC-AS2 in colorectal cancer and its potential mechanisms. Firstly, we found that the expression of HOXC-AS2 was down-regulated in colorectal cancer tissues than its adjacent normal tissues, and the expression level of HOXC-AS2 was found to show an inversely correlated with tumor size by analyzing the clinicopathological characteristics. HOXC-AS2 knockdown significantly increased its proliferation and colony formation ability in colorectal cancer cells, and conversely, HOXC-AS2 overexpression significantly decreased its proliferation and colony formation ability, suggesting that HOXC-AS2 exerts anti-tumor effect in colorectal cancer. In addition, we found that miR-146b-5p, as a downstream bioactive factor, could be targeting sponged by HOXC-AS2 in colorectal cancer, and the expression of UBE2L6 was regulated by miR-146b-5p. Thus, HOXC-AS2 inhibits the proliferation and colony formation ability in colorectal cancer cells by targeted sponging miR-146b-5p and then regulates UBE2L6.

Publisher

American Scientific Publishers

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Reference48 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3